Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2005
12/07/2005EP1602371A2 Valproic acid and derivatives for the sensitisation of human cancer cells to increase efficacy in a combination therapy
12/07/2005EP1602370A2 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
12/07/2005EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1602367A1 Transdermal delivery system for treatment of cognitive disorders
12/07/2005EP1602362A1 Drug composition having active ingredient adhered at high concentration to spherical core
12/07/2005EP1463408A4 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1439840B1 Monobactam antibacterial compounds and methods of use thereof
12/07/2005EP1425381A4 Emu-based formulations for wound treatment related application information
12/07/2005EP1423409A4 Gastrokines and derived peptides including inhibitors
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1316558B9 Tetraphenylbacteriochlorin derivatives and compositions containing the same
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1270584B1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1217001B1 Quinuclidine compounds and drugs containing the same as the active ingredient
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1124548B1 Compositions for the treatment and prevention of cardiovascular diseases
12/07/2005EP1117426B1 Akt compositions for enhancing survival of cardiomyocytes
12/07/2005EP1097138B1 Pharmaceutical compositions comprising 2-quinolones
12/07/2005EP1089727B1 Liposomal formulations of busulphan
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP1064263B1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/07/2005EP1017394B1 Cyclin dependent kinase inhibiting purine derivatives
12/07/2005EP0998568B1 Mutant having uracil phosphoribosyl transferase activity
12/07/2005EP0981523B1 Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005EP0724589B1 A method for enhancing neurone survival and agents useful for same
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705478A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/07/2005CN1704478A Methods for assessing patients with acute myeloid leukemia
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1704114A Synergistic antiplaque antigingivitis oral composition
12/07/2005CN1230540C Drosophila recombination-associated protein and methods for use
12/07/2005CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain
12/07/2005CN1230442C GnRh antagonists being modified in positions 5 and 6
12/07/2005CN1230441C Integrin binding peptide derivatives
12/07/2005CN1230436C Imidazo[1,5,-a] pyrimido[5,4-d]benzazepine derivatives as GABAA receptor modulators
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230423C 1,4-disubstituted piperazine derivatives useful as uro-selective dollar g(a)1-adrenoceptor blockers
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230416C Pharmaceutical compounds
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230199C Use of nitric oxide for treatment of airway constriction
12/07/2005CN1230196C Erythropoiesis for treating anemia of family and raised animals
12/07/2005CN1230179C Micronized eplerenone compositions
12/07/2005CN1230174C Selective iGLuR5 receptor antagonists for the treatment of migraine
12/07/2005CN1230173C Preventives and remedies for complications of diabetes
12/07/2005CN1230172C Blood circulation improving agent
12/07/2005CN1230171C Treating diabetes by thiazolidine-diketo and dimethylbiguanide
12/07/2005CN1230169C Use of cyclopamine in the treatment of psoriasis
12/07/2005CN1230168C Agent with an antidepressive effect
12/07/2005CN1230167C Dual-release compositions of cyclooxygenase-2-inhibitor
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/07/2005CN1230164C Combinations of(S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxion[2,3-e]indol-8-one and neuroleptics
12/07/2005CN1230148C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
12/07/2005CN1230141C Improved stability for injection solutions
12/06/2005USRE38912 for treating a number of complaints, particularly respiratory diseases
12/06/2005US6972343 such as N,N'-diformyl-N,N'-di[1-methyl-2-S-thiobenzoyl-4-methoxybut-1-enyl]-1,12-diaminododecane; for treatment of malaria
12/06/2005US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005US6972168 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture
12/06/2005CA2362834C Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2331873C Fumagillol derivatives and processes for preparing the same
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/06/2005CA2268866C Substituted arylalkylamines as neurokinin antagonists
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/03/2005CA2529613A1 Agent for repairing corneal sensitivity containing amide compound
12/02/2005CA2509077A1 Water-based compositions comprising a polyethylene glycol-based solubilizing agent and a taxane useful in the treatment of coronary artery disease
12/01/2005WO2005113550A1 Aminopyrimidine derivative and medicinal use thereof
12/01/2005WO2005113540A1 Isoquinoline compound and pharmaceutical use thereof
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005112904A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same
12/01/2005WO2005027831A3 Modulators of p-selectin glycoprotein ligand 1
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery
12/01/2005WO2002092012A3 Compositions and methods for treating tumors bearing hmfg and cea antigens
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267208 Nordihydroguaiartic derivatives for use in treatment of tumors
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267203 Carbamate compounds for use in preventing or treating anxiety disorders
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267195 Drug composition for blood sugar control
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 1564